3-(4-fluoro-5-(3-fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Catalog No.: 
ACSEWV780
CAS No.: 
-
Molecular Formula: 
C28H24F2N2O3
Molecular Weight: 
474.51
3-(4-fluoro-5-(3-fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$665.00In stock1 week
250mg95%$1330.00In stock1 week
1g95%$3990.00In stock1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-fluoro-5-(3-fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IUPAC Name3-(4-fluoro-5-(3-fluoro-4'-propyl-[1,1'-biphenyl]-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Molecular FormulaC28H24F2N2O3
Molecular Weight474.51
SMILESCCCC1=CC=C(C2=CC=C(C3=CC=C4C(=O)N(C5CCC(=O)NC5=O)CC4=C3F)C(F)=C2)C=C1
InChI KeyHYLPZIYXIRTQFR-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACSEWV780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNMBZ478 route compound structure diagram
    ACNMBZ478134150-01-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSEWV780 route product structure diagram
    ACSEWV780-In Stock
Inquiry

2. ACSEWV780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKIGF106 route compound structure diagram
    ACKIGF1062408391-89-7In Stock
  4. Then
  5. ACSEWV780 route product structure diagram
    ACSEWV780-In Stock
Inquiry

3. ACSEWV780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYMXE630 route compound structure diagram
    ACYMXE630909709-42-8In Stock
  2. Plus
  3. ACKIGF106 route compound structure diagram
    ACKIGF1062408391-89-7In Stock
  4. Then
  5. ACSEWV780 route product structure diagram
    ACSEWV780-In Stock
Inquiry

Comments (0)